Overview

Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects

Status:
Terminated
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This is a brief inpatient study to determine the safety of a new drug in healthy people.
Phase:
Phase 1
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
National Institute of Mental Health (NIMH)